All Phenotypes Rpl27a<Sfa> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Rpl27a^Sfa/Rpl27a^Sfa	C57BL/6J-Rpl27a^Sfa	MGI:5140352
ht2	Rpl27a^Sfa/Rpl27a⁺	C57BL/6J-Rpl27a^Sfa	MGI:5140353
cx3	Rpl27a^Sfa/Rpl27a⁺ Trp53^tm1Tyj/Trp53⁺	B6.Cg-Rpl27a^Sfa Trp53^tm1Tyj	MGI:5140357
cx4	Rpl27a^Sfa/Rpl27a⁺ Trp53^tm1Tyj/Trp53⁺	involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J	MGI:5140356
cx5	Rpl27a^Sfa/Rpl27a⁺ Trp53^tm1Tyj/Trp53^tm1Tyj	involves: 129S2/SvPas * C57BL/6J	MGI:5140354
cx6	Rpl27a^Sfa/Rpl27a^Sfa Trp53^tm1Tyj/Trp53^tm1Tyj	involves: 129S2/SvPas * C57BL/6J	MGI:5140355
cx7	In(11Trp53;11Wnt3)8Brd/+ Rpl27a^Sfa/Rpl27a⁺	involves: 129S7/SvEvBrd * C57BL/6J	MGI:5140360
cx8	Mdm2^tm1Bay/Mdm2⁺ Rpl27a^Sfa/Rpl27a⁺	involves: 129S7/SvEvBrd * C57BL/6J	MGI:5140361
cx9	Mdm4^tm1Glo/Mdm4⁺ Rpl27a^Sfa/Rpl27a⁺	involves: C57BL/6J	MGI:5140362
cx10	Rpl27a^Sfa/Rpl27a⁺ Tg(Dct-lacZ)#Ove/0	involves: C57BL/6J * FVB/N	MGI:5140358

Allelic Composition	Rpl27a^Sfa/Rpl27a^Sfa
Genetic Background	C57BL/6J-Rpl27a^Sfa

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rpl27a^Sfa mutation (0 available); any Rpl27a mutation (52 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality, complete penetrance ( J:174216 )

• all die before E7.5

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

increased mortality induced by gamma-irradiation ( J:174216 )

• minimally affected mice (near normal body weight and minimal ataxia) all died less than 20 days after treatment with a sub-lethal (for wild-type controls) dose of gamma irradiation

postnatal lethality, incomplete penetrance ( J:174216 )

• about 20% of affected mice die in early postnatal development

behavior/neurological

ataxia ( J:174216 )

• variable penetrance

• cerebellar ataxia with an unsteady gait and consistent falling

impaired coordination ( J:174216 )

growth/size/body

increased ear pigmentation ( J:174216 )

• fully penetrant hyperpigmentation of the ears

decreased body weight ( J:174216 )

• variable penetrance

postnatal growth retardation ( J:174216 )

• seriously affected mice are unable to undertake the rapid growth spurt that normally occurs 19 - 30 days after birth

pigmentation

hyperpigmentation ( J:174216 )

• fully penetrant hyperpigmentation of the tail, feet, ears and genital areas

increased ear pigmentation ( J:174216 )

• fully penetrant hyperpigmentation of the ears

increased foot pad pigmentation ( J:174216 )

increased tail pigmentation ( J:174216 )

• fully penetrant hyperpigmentation of the tail

hematopoietic system

increased hematopoietic stem cell proliferation ( J:174216 )

• significant increase in proliferation

• mice with the lowest HSC numbers have the highest proportion of proliferating HSCs

abnormal hematopoietic system morphology/development ( J:174216 )

• thin, watery blood in severely affected mice

small thymus ( J:174216 )

anemia ( J:174216 )

• variable penetrance

• bone marrow sections show hypocellularity indicative of aplastic anemia

decreased bone marrow cell number ( J:174216 )

• bone marrow sections show hypocellularity indicative of aplastic anemia

decreased hematopoietic cell number ( J:174216 )

decreased erythrocyte cell number ( J:174216 )

• 46% of wild-type numbers in affected mice

thrombocytopenia ( J:174216 )

• 30% of wild-type numbers in affected mice

decreased leukocyte cell number ( J:174216 )

• 14% of wild-type numbers in affected mice

decreased hematopoietic stem cell number ( J:174216 )

• about 40% of wild-type numbers in severely affected mice

pancytopenia ( J:174216 )

• in severely affected mice

small spleen ( J:174216 )

abnormal bone marrow cell physiology ( J:174216 )

• significant increase in bone marrow cell apoptosis in some mice

nervous system

abnormal cerebellum external granule cell layer morphology ( J:174216 )

• reduction in the number of proliferating cells and increase in apoptosis at P3

thin external granule cell layer ( J:174216 )

• small EGL at P2

abnormal cerebellar layer morphology ( J:174216 )

• severely disrupted layers at 12 -14 weeks

abnormal Purkinje cell morphology ( J:174216 )

• Purkinje neurons are disorganized in the cerebellum at 12 -14 weeks of age

ectopic Purkinje cell ( J:174216 )

• found ectopically located throughout the cerebellum at 12 -14 weeks of age

abnormal cerebellar granule layer morphology ( J:174216 )

• pronounced reduction in cell numbers at 12 - 14 weeks of age

decreased cerebellar granule cell number ( J:174216 )

small cerebellum ( J:174216 )

integument

increased ear pigmentation ( J:174216 )

• fully penetrant hyperpigmentation of the ears

increased foot pad pigmentation ( J:174216 )

increased tail pigmentation ( J:174216 )

• fully penetrant hyperpigmentation of the tail

limbs/digits/tail

increased foot pad pigmentation ( J:174216 )

increased tail pigmentation ( J:174216 )

• fully penetrant hyperpigmentation of the tail

immune system

small thymus ( J:174216 )

decreased leukocyte cell number ( J:174216 )

• 14% of wild-type numbers in affected mice

small spleen ( J:174216 )

craniofacial

increased ear pigmentation ( J:174216 )

• fully penetrant hyperpigmentation of the ears

hearing/vestibular/ear

increased ear pigmentation ( J:174216 )

• fully penetrant hyperpigmentation of the ears

cellular

increased hematopoietic stem cell proliferation ( J:174216 )

• significant increase in proliferation

• mice with the lowest HSC numbers have the highest proportion of proliferating HSCs

homeostasis/metabolism

increased mortality induced by gamma-irradiation ( J:174216 )

• minimally affected mice (near normal body weight and minimal ataxia) all died less than 20 days after treatment with a sub-lethal (for wild-type controls) dose of gamma irradiation

endocrine/exocrine glands

small thymus ( J:174216 )

Allelic Composition	Rpl27a^Sfa/Rpl27a⁺ Trp53^tm1Tyj/Trp53⁺
Genetic Background	B6.Cg-Rpl27a^Sfa Trp53^tm1Tyj

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rpl27a^Sfa mutation (0 available); any Rpl27a mutation (52 available)
Trp53^tm1Tyj mutation (12 available); any Trp53 mutation (232 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

behavior/neurological phenotype ( J:174216 )

N	• motor coordination is similar to Trp53 heterozygous controls

pigmentation

increased foot pad pigmentation ( J:174216 )

hematopoietic system

hematopoietic system phenotype ( J:174216 )

N	• no bone marrow deficiencies are detected

nervous system

nervous system phenotype ( J:174216 )

N	• no cerebellar deficiencies are detected

integument

increased foot pad pigmentation ( J:174216 )

limbs/digits/tail

increased foot pad pigmentation ( J:174216 )

Allelic Composition	Rpl27a^Sfa/Rpl27a⁺ Trp53^tm1Tyj/Trp53⁺
Genetic Background	involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

increased tumor-free survival time ( J:174216 )

• prolonged survival compared to mice heterozygous for the Trp53 allele alone

neoplasm

increased metastatic potential ( J:174216 )

• compared to mice heterozygous for the Trp53 allele alone

abnormal tumor incidence ( J:174216 )

• increase in tumor type multiplicity compared to mice heterozygous for the Trp53 allele alone

decreased lymphoma incidence ( J:174216 )

• compared to mice heterozygous for the Trp53 allele alone

increased tumor latency ( J:174216 )

• tumors appear at about 13 months of age compared to about 9 months of age in mice heterozygous for the Trp53 allele alone

Allelic Composition	Rpl27a^Sfa/Rpl27a⁺ Trp53^tm1Tyj/Trp53^tm1Tyj
Genetic Background	involves: 129S2/SvPas * C57BL/6J

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

pigmentation

pigmentation phenotype ( J:174216 )

N	• foot pad hyperpigmentation is not seen unlike in mice wild-type for Trp53

Allelic Composition	Rpl27a^Sfa/Rpl27a^Sfa Trp53^tm1Tyj/Trp53^tm1Tyj
Genetic Background	involves: 129S2/SvPas * C57BL/6J

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality, complete penetrance ( J:174216 )

Allelic Composition	In(11Trp53;11Wnt3)8Brd/+ Rpl27a^Sfa/Rpl27a⁺
Genetic Background	involves: 129S7/SvEvBrd * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
In(11Trp53;11Wnt3)8Brd mutation (1 available); any In(11Trp53;11Wnt3)8Brd mutation (4 available)
Rpl27a^Sfa mutation (0 available); any Rpl27a mutation (52 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

normal phenotype

no abnormal phenotype detected ( J:174216 )

• mice do not display ataxia or foot pad hyperpigmentation

Allelic Composition	Mdm2^tm1Bay/Mdm2⁺ Rpl27a^Sfa/Rpl27a⁺
Genetic Background	involves: 129S7/SvEvBrd * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mdm2^tm1Bay mutation (1 available); any Mdm2 mutation (54 available)
Rpl27a^Sfa mutation (0 available); any Rpl27a mutation (52 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

prenatal lethality, complete penetrance ( J:174216 )

• no pups are born

Allelic Composition	Mdm4^tm1Glo/Mdm4⁺ Rpl27a^Sfa/Rpl27a⁺
Genetic Background	involves: C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mdm4^tm1Glo mutation (0 available); any Mdm4 mutation (191 available)
Rpl27a^Sfa mutation (0 available); any Rpl27a mutation (52 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

prenatal lethality, complete penetrance ( J:174216 )

• no pups are born

Allelic Composition	Rpl27a^Sfa/Rpl27a⁺ Tg(Dct-lacZ)#Ove/0
Genetic Background	involves: C57BL/6J * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rpl27a^Sfa mutation (0 available); any Rpl27a mutation (52 available)
Tg(Dct-lacZ)#Ove mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

pigmentation

abnormal epidermal melanocyte morphology ( J:174216 )

• dramatic increase in epidermal melanocyte numbers with increased deposition of melanin granules in the foot pads and tail

hyperpigmentation ( J:174216 )

• dramatic increase in epidermal melanocyte numbers with increased deposition of melanin granules

increased foot pad pigmentation ( J:174216 )

increased tail pigmentation ( J:174216 )

• hyperpigmentation of the tail

integument

abnormal epidermal melanocyte morphology ( J:174216 )

• dramatic increase in epidermal melanocyte numbers with increased deposition of melanin granules in the foot pads and tail

increased foot pad pigmentation ( J:174216 )

increased tail pigmentation ( J:174216 )

• hyperpigmentation of the tail

limbs/digits/tail

increased foot pad pigmentation ( J:174216 )

increased tail pigmentation ( J:174216 )

• hyperpigmentation of the tail

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 05/21/2024 MGI 6.23